The question my father in law asked his hepatologist, the one he had clearly been rehearsing in the car, was: "Is it too late?" He was 58, had fatty liver disease with early scarring, and had spent the week between the blood test and the appointment reading forum posts by people with cirrhosis. The consultant, a calm woman who had plainly heard the question a thousand times, said: "For you, no. Your liver is the most forgiving organ you own. Let me show you how far back it can go."
That answer depends entirely on two things: what is causing the damage, and how much scar there already is. This article walks through both, honestly. It covers what "cure" means for each type of liver disease, the new medicines that have arrived since 2024, when cirrhosis can still improve and when it cannot, and what happens at the transplant end of the road. Every claim is linked to the study or guideline behind it.
This article is for information only. Liver disease is managed by hepatologists and gastroenterologists, and treatment decisions depend on your individual tests. Please use it to ask better questions, not to replace them.
Can a damaged liver heal itself?
Yes, up to a point that is further along than most people think. The liver regenerates in a way no other solid organ does: after surgery removing 70 percent of it, the remaining tissue grows back to full size in weeks. Scar tissue is the limit. Fibrosis is laid down by cells called stellate cells in response to ongoing injury, and when the injury stops those cells switch off and the body slowly reabsorbs the scar. Paired biopsy studies have shown fibrosis regressing in hepatitis C after cure (D'Ambrosio 2012), in hepatitis B on antivirals (Marcellin 2013, where 74 percent of patients with cirrhosis no longer had it after five years of tenofovir), in alcohol related disease after abstinence, and in fatty liver after weight loss.
The line that matters is decompensation: the point where cirrhosis stops being silent and produces fluid in the abdomen (ascites), bleeding from swollen veins in the gullet (varices), confusion (encephalopathy) or jaundice. Before that line, removing the cause changes survival dramatically. After it, treatment shifts to managing complications and, for suitable people, transplant.
First, know your stage
You cannot talk sensibly about treatment without staging, and staging has become far easier. A decade ago it meant a biopsy. Now it usually means a FIB-4 score from routine bloods and, if that is raised, a FibroScan, a painless ten minute ultrasound that measures liver stiffness in kilopascals.
| FibroScan reading | Approximate meaning | Usual next step |
|---|---|---|
| Under 8 kPa | Little or no significant scarring | Lifestyle change, repeat in 2 to 3 years |
| 8 to 12 kPa | Possible significant fibrosis (F2 to F3) | Specialist review, consider medicines, repeat in 12 months |
| 12 to 15 kPa | Advanced fibrosis or early cirrhosis likely | Hepatology care, screen for varices and liver cancer |
| Over 20 kPa | Cirrhosis with raised portal pressure likely | Endoscopy, six monthly ultrasound, close follow up |
Ray's 9.8 kPa put him in the second row. Not cirrhosis, not nothing. The treatment plan flowed directly from that number and from the cause, which was fat.
Treating fatty liver disease (MASLD and MASH)
Weight loss remains the foundation
Every guideline, including the 2024 EASL and 2023 AASLD documents, starts here, because it is the only treatment shown to reverse every stage. The landmark data (Vilar-Gomez 2015) showed that a 10 percent weight loss resolved steatohepatitis in 90 percent of patients and regressed fibrosis in 81 percent. The problem is that only about one in ten people achieves that with diet and exercise alone. That gap is what the new medicines fill.
Your starting point is your current weight and BMI. The BMI calculator shows what a 7 and 10 percent loss means in kilograms for you, with the lower thresholds for people of Asian or Black heritage, whose livers accumulate fat at lower body weights.
The new medicines: what has changed since 2024
For twenty years there was no licensed drug for fatty liver. Since March 2024 there have been two, with more coming.
| Treatment | Key trial | Result | Where it sits |
|---|---|---|---|
| Resmetirom (Rezdiffra), a thyroid hormone receptor drug taken as a daily tablet | MAESTRO-NASH, NEJM 2024, 966 patients | MASH resolved in 30 percent vs 10 percent placebo; fibrosis improved in 26 percent vs 14 percent | First FDA approved MASH drug (March 2024), EU conditional approval 2025. For F2 to F3 fibrosis |
| Semaglutide 2.4 mg weekly (Wegovy) | ESSENCE, NEJM 2025, 800 patients | MASH resolved in 63 percent vs 34 percent; fibrosis improved in 37 percent vs 23 percent | FDA approved for MASH August 2025. Also treats the obesity and diabetes driving it |
| Tirzepatide (Mounjaro) | SYNERGY-NASH, NEJM 2024, phase 2 | MASH resolved in up to 74 percent vs 13 percent | Phase 3 ongoing; widely used off label for weight |
| Pioglitazone | PIVENS, NEJM 2010 | MASH resolved in 34 percent vs 19 percent | Cheap, effective in diabetics, causes some weight gain |
| Vitamin E 800 IU | PIVENS | MASH resolved in 36 percent vs 21 percent | Option for non diabetics without cirrhosis; long term safety debated |
| Bariatric surgery | Lassailly 2020 | MASH resolved in 84 percent at five years, fibrosis regressed in 70 percent | For BMI over 35 with complications, or over 40 |
The practical hierarchy in 2026 looks like this. If you have fatty liver with no or minimal scarring, lifestyle change alone is appropriate. If you have F2 or F3 fibrosis, you should be under specialist care and a medicine should be discussed: semaglutide or tirzepatide if you also have obesity or diabetes, resmetirom if you do not, pioglitazone if cost is the barrier. If your BMI is above 35, surgery deserves an honest conversation. We cover the wider picture of these medicines, including regain after stopping, in obesity treatment: can it be cured?
Ray was offered semaglutide and declined it, at least initially. He wanted to try the lifestyle route first and his consultant agreed to a twelve month window. It worked for him. It does not for most, and there is no shame in taking the medicine.
Treating alcohol related liver disease
The treatment is abstinence, and the evidence for it is stark. In a study of 192 people with alcohol related cirrhosis published in the Journal of Hepatology 2017, those who stopped drinking completely had a ten year survival around 60 percent; those who continued had about 30 percent. Even in decompensated cirrhosis, abstinence roughly doubled survival. Cutting down is not the same as stopping; for a scarred liver, the safe amount of alcohol is none.
Stopping is a medical process, not a matter of willpower. Withdrawal from heavy dependent drinking can be dangerous and should be supervised. Medicines like acamprosate, naltrexone and baclofen help people stay stopped, and the NICE guidance is that they should be offered routinely. For severe alcoholic hepatitis, a sudden inflammatory crisis, a month of prednisolone improves short term survival in selected patients (STOPAH trial, NEJM 2015).
Curing hepatitis C and controlling hepatitis B
Hepatitis C is the great success story of modern medicine. It went from a six percent cure rate with interferon injections in 1990 to over 95 percent with 8 to 12 weeks of tablets, and those tablets are on the NHS and widely available worldwide.
Hepatitis B cannot yet be cured, but it can be controlled almost completely with a daily tablet (tenofovir or entecavir) that suppresses the virus, and long term suppression reverses cirrhosis in most patients and cuts liver cancer risk by more than half (Marcellin 2013). If you have either infection, the treatment decision is straightforward: take it.
Living with and treating cirrhosis
A diagnosis of cirrhosis frightens people, and it should be taken seriously, but it is not a single prognosis.
If you have compensated cirrhosis, the priorities from the Baveno VII consensus and NICE are:
- Remove the cause. Stop alcohol entirely, treat the virus, lose the weight. This is what moves you from the second bar to the first.
- Screen for liver cancer with an ultrasound every six months. Cirrhosis is the main risk factor for hepatocellular carcinoma, and caught small it is curable.
- Prevent variceal bleeding. An endoscopy or a FibroScan and platelet count decides whether you need a beta blocker like carvedilol, which the PREDESCI trial showed reduces decompensation (Villanueva 2019).
- Eat enough protein and do not fast overnight. Muscle loss is a major driver of poor outcomes in cirrhosis. The advice is 1.2 to 1.5 g of protein per kg per day and a late evening snack, the opposite of most diets. Our liver disease diet guide explains this in detail.
- Get vaccinated against hepatitis A and B, flu, pneumococcus and COVID, because infections tip compensated cirrhosis into decompensation.
- Avoid NSAIDs (ibuprofen, naproxen) which can trigger kidney failure and bleeding. Paracetamol at up to 2 to 3 g a day is actually the safer painkiller in cirrhosis, which surprises people.
Decompensated cirrhosis is managed with diuretics and salt restriction for fluid, lactulose and rifaximin for confusion, banding for varices, and sometimes a TIPS procedure to lower pressure in the portal vein. And it is the point at which transplant assessment begins.
Liver transplant: the last cure
A transplant is a genuine cure for the failing liver, with one year survival around 90 percent and five year survival around 75 percent in the UK (NHS Blood and Transplant). About 1,000 are done a year in the UK and 10,000 in the US. Candidates are assessed on how sick their liver is (the MELD or UKELD score), whether they are fit enough for major surgery, and, for alcohol related disease, whether they are engaged with staying abstinent. The old rigid six month sobriety rule has softened; the evidence shows carefully selected patients with severe alcoholic hepatitis do as well as others (Mathurin 2011).
The waiting list is the hard part. Around one in ten people die waiting. That is one more reason early treatment matters so much: almost everyone on the list had a stage, years earlier, where a blood test and a change of habits would have prevented it.
Ray, fourteen months later
His repeat FibroScan read 6.1 kPa, normal. His enzymes were normal. He had lost 11 kg without medication, though he told me later that if it had not worked he would have taken the injection and been glad of it. His consultant discharged him. "I see a lot of people in this clinic ten years too late," she said. "You are the version of that where it goes right."
If you are reading this because your own liver tests came back off, or because someone you love has just been told they have cirrhosis, please hold on to the shape of the evidence rather than the worst forum post. Almost every kind of liver disease has an effective treatment now. The earlier you find out your stage, the more of those treatments are open to you, and the more of your liver will still be there to do the healing.
Read next
- How to prevent liver disease: causes, risk factors and 7 habits that work
- Liver disease diet and exercise plan: foods to eat and avoid
- BMI calculator: your healthy weight range and what 10 percent looks like
- Obesity treatment: drugs, diet and surgery compared
- How to get rid of gallstones: with and without surgery
Frequently asked questions
Can liver damage be reversed?
Yes, in most cases. Fatty liver, inflammation and early to moderate fibrosis can all regress once the cause is removed. Compensated cirrhosis can stabilise and partly improve. Decompensated cirrhosis usually cannot, and transplant becomes the cure.
How long does it take for the liver to heal?
Liver fat falls within weeks of cutting sugar and alcohol. Enzymes often normalise within three months. Fibrosis regresses slowly, typically over one to three years, and stiffness scans are usually repeated at twelve months.
Is there a cure for fatty liver disease?
Weight loss of 7 to 10 percent resolves it in most people. Two medicines, resmetirom and semaglutide, are now licensed for the inflammatory form (MASH) with fibrosis, and tirzepatide is in phase 3 trials.
Can you live a normal life with cirrhosis?
Many people with compensated cirrhosis live for decades, especially if the cause is removed and they attend six monthly cancer screening. Life expectancy falls sharply after decompensation, which is why prevention of that step is the focus of care.
What is the life expectancy after a liver transplant?
About 90 percent of recipients are alive at one year and around 75 percent at five years in the UK, and many live 20 years or more.
